Advances in Microbial Biofilm Prevention on Indwelling Medical Devices with Emphasis on Usage of Acoustic Energy

Sensors

Volumn 9, Issue 4, 2009, Pages 2538-2554

  Dror, Naama ^a   Mandel, Mathilda ^b   Hazan, Zadik ^c   Lavie, Gad ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c Regenera Pharma Ltd   (Israel)

Author keywords

Acoustic energy; Anti microbial agents; Biofilm prevention; Biofilms; Ultrasonication

Indexed keywords

ANTIMICROBIAL AGENTS; BIOMEDICAL EQUIPMENT;

'CURRENT; ACOUSTIC ENERGY; ANTI-MICROBIAL AGENT; BIOFILM FORMATION; BIOFILM PREVENTION; MECHANICAL; MEDICAL DEVICES; MICROBIAL BIOFILM; POLYSACCHARIDE COATINGS; ULTRA-SONICATION;

BIOFILMS;

EID: 70849092484     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s90402538     Document Type: Review

References (78)

1. Donlan, R.M. Biofilm formation: a clinically relevant microbiological process. Clin. Infect. Dis. 2001, 33, 1387-1392.
2. Maki, D.G.; Merme, L.A. Infections due to infusion therapy. In Hospital Infections, 4th Edtion; Bennet J.V., Brachman P.S., Eds.; Lippincott-Raven: Philadelphia, 1998; pp. 689-724.
3. Raad, I. Intravascular-catheter-related infections. Lancet 1998, 351, 893-898.
4. Maki, D.G.; Tambyah, P.A. Engineering out the risk of infection with urinary catheters. Emerging Infect. Dis. 2001, 7, 1-6.
5. Costerton, J.W. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284, 1318-1322.
6. Schachter, B. Slimy business—the biotechnology of biofilms. Nat. Biotechnol. 2003, 21, 361-365.
7. Branda, S.S.; Vik, A.S.; Friedman, L.; Kolter, R. Biofilms: the matrix revisited. Trends Microbiol. 2005, 13.
8. Parsek, M.R. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol. 2003, 57, 677-701.
9. Anwar, H.; Strap, J.L.; Costerton, J.W. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 1992, 36, 1347-1351.
10. Nichols, W.W.; Dorrington, S.M.; Slack, M.P.E.; Walmsley, H.L. Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents Chemother. 1988, 32, 518-523.
11. Brown, M.R.W.; Allison, D.G.; Gilbert, P. Resistance of bacterial biofilms to antibiotics: a growth-rate related effect? J. Antimicrob. Chemother. 1988, 22, 777-783.
12. Mahenthiralingam, E.; Campbell, M.E.; Speert, D.P. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 1994, 62, 596-605.
13. Kristian, S.A.; Birkenstock, T.A.; Sauder, U.; Mack, D.; Götz, F.; Landmann, R. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J. Infect. Dis. 2008, 197, 1028-1035.
14. Walker, T.S.; Tomlin K.L.; Worthen, G.S.; Poch, K.R.; Lieber, J.G.; Saavedra, M.T.; Fessler, M.B.; Malcolm, K.C.; Vasil, M.L.; Nick, J.A. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect. Immun. 2005, 73, 3693-3701.
15. Singh, P.K.; Parsek, M.R.; Greenberg, E.P.; Welsh, M.J.A component of innate immunity prevents bacterial biofilm development. Nature 2002, 417, 552-555.
16. Martinez, L.R.; Casadevall, A. Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system. Infect. Immun. 2006, 74, 6118-6123.
17. Riley, D.K. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. The Amer. J. Medicine 1995, 98, 349-356.
18. Kollef, M.H.; Afessa, B.; Anzueto, A.; Veremakis, C.; Kerr, K.M.; Margolis, B.D.; Craven, D.E.; Roberts, P.R.; Arroliga, A.C.; Hubmayr, R.D.; Restrepo, M.I.; Auger, W.R.; Schinner, R. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. J. Amer. Med. Assoc. 2008, 300, 805-813.
19. Shah, C.B.; Mittelman, M.W.; Costerton, J.W.; Parenteau, S.; Pelak, M.; Arsenault, R.; Mermel, L.A. Antimicrobial activity of a novel catheter lock solution. Antimicrob. Agents Chemother. 2002, 46, 1674-1679.
20. Krzywda, E.A.; Andris, D.A.; Edminston, C.E.; Quebbeman, E.J. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect. Control Hosp. Epidemiol. 1995, 16, 596-598.
21. Krishnasami, Z.; Carlton, D.; Bimbo, L.; Taylor, M.E.; Balkovetz, D.F.; Baker, J.; Allon; M. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int. 2002, 61, 1136-1142.
22. Raad, I.; Chatzinikolaou, I.; Chaiban, G.; Hanna, H.; Hachem, R.; Dvorak, T.; Cook, G.; Costerton, W. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob. Agents Chemother. 2003, 47, 3580-3585.
23. Cateau, E.; Rodier, M.H.; Imbert, C. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. J. Antimicrob Chemother. 2008, 62, 153-155.
24. van Heerden, J.; Turner, M.; Hoffmann, D.; Moolman, J. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented? J. Plast Reconstr Aesthet Surg. 2008, in press.
25. Doig, P.; Todd, T.; Sastry, P.A.; Lee, K.K., Hodges, R.S., Paranchych, W.; Irvin, R.T. Role of pili in adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells. Infect. Immun. 1988, 56, 1641-1646.
26. Hultgren, S.J.; Lindberg, F.; Magnusson, G.; Kihlberg, J.; Tennent, J.M.; Normark, S. The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 4357-4361.
27. Yilmaz, O.; Watanabe, K.; Lamont, R.J. Involvement of integrins in fimbriae-mediated binding and invasion by Porphyromonas gingivalis. Cell. Microbiol. 2002, 4, 305-314.
28. Merino, S.; Rubires, X.; Aguilar, A.; Tomas, J.M. The role of flagella and motility in the adherence and invasion to fish cell lines by Aeromonas hydrophila serogroup O:34 strains. FEMS Microbiol. Lett. 1997, 151, 213-217.
29. Azghani, A.O.; Idell, S.; Bains, M.; Hancock, R.E.W. Pseudomonas aeruginosa outer membrane protein F is an adhesin in bacterial binding to lung epithelial cells in culture. Microb. Pathog. 2002, 33, 109-114.
30. Busscher, H.J.; Weerkamp, A.H. Specific and non-specific interactions in bacterial adhesion to solid substrate. FEMS Microbiol. Rev. 1987, 46, 165-174.
31. Saiman, L.; Prince, A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 1993, 92, 1875-1880.
32. Buts, L.; Bouckaert, J.; De Genst, E.; Loris, R.; Oscarson, S.; Lahmann, M.; Messens, J.; Brosens, E.; Wyns, L.; De Greve, H. The fimbrial adhesin F17-G of enterotoxigenic Escherichia coli has an immunoglobulin-like lectin domain that binds N-acetylglucosamine. Mol. Microbiol. 2003, 49, 705-715.
33. Tong, H.H.; Liu, X.; Chen, Y.P.; James, M.; DeMaria, T. Effect of neuraminidase on receptor-mediated adherence of Streptococcus pneumoniae to chinchilla tracheal epithelium. Acta Otolaryngol. 2002, 122, 413-419.
34. Simon, P.M.; Goode, P.L.; Mobasseri, A.; Zopf, D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infect. Immun. 1996, 65, 750-757.
35. Schumm, K.; Lam TB. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version cochrane review. Neurourol Urodyn. 2008, 27, 738-746.
36. Erickson, B.A.; Navai, N.; Patil, M.; Chang, A.; Gonzalez, C.M. A prospective, randomized trial evaluating the use of hydrogel coated latex versus all silicone urethral catheters after urethral reconstructive surgery. J Urol. 2008, 179, 203-206.
37. Tenke, P.; Riedl, C.R.; Jones, G.L.; Williams, G.J.; Stickler, D.; Nagy, E. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int. J. Antimicrob. Agents 2004, 23, S67-S74.
38. Lewis, K.; Klibanov, A.M. Trends Biotechnol. 2005, 23, 343-348.
39. Gottenbos B, van der Mei HC, Klatter F, Nieuwenhuis P, Busscher HJ. In vitro and in vivo antimicrobial activity of covalently coupled quaternary ammonium silane coatings on silicone rubber. Biomaterials 2002, 23, 1417-1423.
40. Trautner, B.W.; Darouich, R.O. Catheter associated infections pathogenesis affect prevention. Arch. Intern. Med. 2004, 164, 842-850.
41. Cox, A.J.; Millington, R.S.; Hukins, D.W.L.; Sutton, T.M. Resistance of catheters coated with a modified hydrogel to encrustation during an in vitro test. Urol. Res. 1989, 17, 353-356.
42. Deretic, V.; Schurr, M.J.; Boucher, J.C. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factor. J. Bacteriol. 1994, 176, 2773-2780.
43. Stewart, P.S. Biofilm Accumulation Model that Predicts Antibiotic Resistance of Pseudomonas aeruginosa Biofilms. Antimicrob. Agents Chemother. 1994, 38, 1052-1058.
44. Stewart, P.S. Theoretical Aspects of Antibiotic Diffusion into Microbial Biofilms. Antimicrob. Agents Chem. 1996, 40, 2517-2522.
45. Azeredo, J.; Sutherland, I.W. The use of phages for the removal of infectious biofilms. Curr. Pharm. Biotechnol. 2008, 9, 261-266.
46. Beckmann, C.; Brittnacher, M.; Ernst, R.; Mayer-Hamblett, N.; Miller, S.I.; Burns, J.L. Use of phage display to identify potential Pseudomonas aeruginosa gene products relevant to early cystic fibrosis airway infections. Infect. Immun. 2005, 73, 444-452.
47. Hughes, K.A.; Sutherland, I.W.; Clark, J.; Jones, M.V. Bacteriophage and associated polysaccharide depolymerases--novel tools for study of bacterial biofilms. J. Appl. Microbiol. 1998, 85, 583-590.
48. Brozel, V.S.; Strydom, G.M.; Cloete, T.E. A method for the study of de novo protein synthesis in Pseudomonas aeruginosa after attachment. Biofouling 1995, 8, 195-210.
49. Davies, D.G.; Chakrabarty, A.M.; Geesey, G.G. Exopolysaccharide production in biofilms: substratum activation of alginate gene expression by Pseudomonas aeruginosa. Appl. Environ. Microbiol. 1993, 59, 1181-1186.
50. Sauer, K.; Camper, A.K. Characterization of phenotypic changes in Pseudomonas putida in response to surface-associated growth. J. Bacteriol. 2001, 183, 6579-6589.
51. Li, Y.H.; Tang, N.; Aspiras, M.B.; Lau, P.C.; Lee, J.H.; Ellen, R.P.; Cvitkovitch, D.G. A quorum-sensing signaling system essential for genetic competence in Streptococcus mutans is involved in biofilm formation. J. Bacteriol. 2002, 184, 2699-2708.
52. Holden, M.T.; Ram Chhabra, S.; de Nys, R.; Stead, P.; Bainton, N.J.; Hill, P.J.; Manefield, M.; Kumar, N.; Labatte, M.; England, D.;et al. Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria. Mol. Microbiol. 1999, 33, 1254-1266.
53. Waters, C.M.; Bassler, B.L. Quorum sensing: cell-to-cell communication in bacteria. Ann. Rev. Cell Dev. Biol. 2005, 21, 319-346.
54. Jayaraman, A.; Wood, T.K. Bacterial quorum sensing: signals, circuits, and implications for biofilms and disease. Annual Rev. Biomed. Eng. 2008, 10, 145-167.
55. Girennavar, B.; Cepeda, M.L.; Soni, K.A.; Vikram, A.; Jesudhasan, P.; Jayaprakasha, G.K.; Pillai, S.D.; Patil, B.S. Grapefruit juice and its furocoumarins inhibits autoinducer signaling and biofilm formation in bacteria. Int. J. Food Microbiol. 2008, 125, 204-208.
56. Qian, Z.; Sagers, R.D.; Pitt, W.G. Investigation of the mechanism of the bioacoustic effect. J. Biomed. Mater. Res. 1999, 44, 198-205.
57. An, Y.H.; Dickinson, R.B.; Doyle, R.J. Mechanisms of bacterial adhesion and pathogenesis of implant and tissue infections. In Handbook of Bacterial Adhesion: Principles, Methods and Applications. Y.H. An; R.J. Friedman Eds.; Humana Press: Totowa, N.J. 2000, pp. 1-27.
58. Pitt, W.G.; Ross, S.A. Ultrasound increases the rate of bacterial cell growth. Biotechnol. Prog. 2003, 19, 1038-1044.
59. Carmen, C.; Nelson, J.L.; Beckstead, B.L.; Runyan, C.M.; Robison, R.A.; Schaalje, G.B.; Pitt, W.G. Ultrasonic-enhanced gentamicin transport through colony biofilms of Pseudomonas aeruginosa and Escherichia coli. J. Infect. Chemother. 2004, 10, 193-199.
60. Qian, Z.; Stoodley, P.; Pitt, W.G. Effect of low intensity ultrasound upon biofilm structure from confocal scanning laser microscopy observation. Biomaterials 1996, 17, 1975-1980.
61. Carmen, J.C.; Roeder, B.L.; Nelson, J.L.; Robison Ogilvie, R.L.; Robison, R.A., Schaalje, G.B.; Pitt, W.G. Treatment of biofilm infections on implants with low-frequency ultrasound and antibiotics. Am. J. Infect. Control. 2005, 33, 78-82.
62. Rediske, A.M.; Roeder, B.L.; Brown, M.K. Ultrasonic enhancement of antibiotic action on Escherichia coli biofilms: an in vivo model. Antimicrob. Agents Chemother. 1999, 43, 1211-1214.
63. Rediske, A.M.; Roeder, B.L.; Nelson, J.L. Pulsed ultrasound enhances the killing of E. coli biofilms by aminoglycoside antibiotics in vivo. Antimicrob. Agents Chemother. 2000, 44, 771-772.
64. Yoshimura, F.; Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J. Bacteriol. 1982, 152, 636-642.
65. Nikaido, H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob. Agents Chemother. 1989, 33, 1831-1836.
66. Nikaido, H.; Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 1985, 49, 1-32.
67. Hancock, R. Aminoglycoside uptake and mode of action---with special reference to streptomycin and gentamicin. II. Effects of aminoglycosides on cells. J. Antimicrob. Chemother. 1981, 8, 429-445.
68. Ensing, G.T.; Roeder, B.L.; Nelson, J.L.; Van Horn, J.R.; Van der Mei, H.C.; Busscher, H.J.; Pitt, W.G. Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo. J. Applied Microbiol. 2005, 99, 443-448.
69. Ensing, G.T.; Neut, D.; Horn, J.R.; Mei, H.C.; Busscher, H.J. The combination of ultrasound with antibiotics released from bone cement decreases the viability of planktonic and biofilm bacteria: an in vitro study with clinical strains. J. Antimicrob. Chemother. 2006, 58, 1287-1290.
70. Sanderson, P.J. Infection in orthopaedic implants. J. Hosp Infect., 1991, 18, 367-375.
71. Carmen, J.C.; Roeder, B.L.; Nelson, J.L.; Beckstead, B.L.; Runyan, C.M.; Schaalje, G.B.; Robison, R.A.; Pitt W.G. Ultrasonically enhanced vancomycin activity against staphylococcus epidermidis biofilms in vivo. J. Biomater. Appl. 2004, 18, 237-245.
72. Oulahal-Lagsir, N.; Martial-Gros, A.; Bonneau, M.; Blum, L.J. "Escherichia coli-milk" biofilm removal from stainless steel surfaces: synergism between ultrasonic waves and enzymes. Biofouling 2003, 19, 159-168.
73. Zips, A.; Schaule, G.; Flemming, H.C. Ultrasound as a means of detaching biofilms. Biofouling 1990, 2, 323-333.
74. Mott, I.E.C.; Stickler, D.J.; Coakley, W.T.; Bott, T.R. The removal of bacterial biofilm from water-filled tubes using axially propagated ultrasound. J. Applied Microbiol. 1998, 84, 509-514.
75. Hazan, Z.; Zumeris, J.; Jacob, H.; Raskin, H.; Kratysh, G.; Vishnia, M.; Dror, N.; Barliya, T.; Mandel, M.; Lavie G. Effective prevention of microbial biofilm formation on medical devices by low-energy surface acoustic waves. Antimicrob. Agents Chemother. 2006, 50, 4144-4152.
76. Leighton, T.G. The Acoustic Bubble; Academic Press: New York, 1997; pp. 526-528.
77. Pitt, W.G. Removal of oral biofilm by sonic phenomena. Am. J. Dent. 2005, 18, 345-352.
78. Parini, M.R.; Pitt, W.G. Removal of oral biofilms by bubbles: the effect of bubble impingement angle and sonic waves. J. Am. Dent. Assoc. 2005, 136, 1688-1693.